Eagle Asset Management Inc Repligen Corp Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Eagle Asset Management Inc holds 273,789 shares of RGEN stock, worth $43.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

273,789

Previous 261,309 4.78%

Holding current value

$43.8 Million

Previous $32.9 Million 23.69%

% of portfolio

0.24%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.79 - $167.35 $1.49 Million - $2.09 Million	12,480 Added 4.78%	273,789 $40.7 Million
Q2 2024 Aug 12, 2024	SELL	$120.0 - $182.95 $1.69 Million - $2.57 Million	-14,059 Reduced 5.11%	261,309 $32.9 Million
Q1 2024 May 09, 2024	SELL	$170.78 - $208.42 $800,616 - $977,072	-4,688 Reduced 1.67%	275,368 $50.6 Million
Q4 2023 Feb 12, 2024	SELL	$114.17 - $185.35 $6.84 Million - $11.1 Million	-59,933 Reduced 17.63%	280,056 $50.4 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $18,735 - $23,828	135 Added 0.04%	339,989 $54.1 Million
Q2 2023 Aug 09, 2023	SELL	$138.42 - $180.31 $18.3 Million - $23.8 Million	-132,051 Reduced 27.98%	339,854 $48.1 Million
Q1 2023 May 08, 2023	SELL	$154.26 - $198.1 $229,847 - $295,169	-1,490 Reduced 0.31%	471,905 $79.4 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $21.9 Million - $29.7 Million	134,809 Added 39.82%	473,395 $80.2 Million
Q3 2022 Nov 07, 2022	SELL	$160.42 - $256.21 $4.31 Million - $6.88 Million	-26,856 Reduced 7.35%	338,586 $63.4 Million
Q2 2022 Aug 10, 2022	BUY	$140.68 - $188.02 $3.3 Million - $4.41 Million	23,447 Added 6.86%	365,442 $59.3 Million
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $4.2 Million - $6.72 Million	26,042 Added 8.24%	341,995 $64.3 Million
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $26,244 - $32,273	-106 Reduced 0.03%	315,953 $82.5 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $1.65 Million - $2.75 Million	8,470 Added 2.75%	316,059 $91.3 Million
Q2 2021 Aug 11, 2021	BUY	$165.87 - $220.95 $42,794 - $57,005	258 Added 0.08%	307,589 $61.4 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $33.3 Million - $41.8 Million	-184,892 Reduced 37.56%	307,331 $60.1 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $19.4 Million - $27.1 Million	131,205 Added 36.34%	492,223 $94.3 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $2.9 Million - $3.74 Million	-23,657 Reduced 6.15%	361,018 $54.4 Million
Q2 2020 Aug 12, 2020	SELL	$94.33 - $140.48 $11.5 Million - $17.2 Million	-122,394 Reduced 24.14%	384,675 $45.8 Million
Q1 2020 May 11, 2020	BUY	$84.96 - $109.14 $349,525 - $449,001	4,114 Added 0.82%	507,069 $49 Million
Q4 2019 Feb 07, 2020	SELL	$73.84 - $93.08 $237,247 - $299,066	-3,213 Reduced 0.63%	502,955 $46.5 Million
Q3 2019 Nov 04, 2019	BUY	$76.65 - $95.51 $2.32 Million - $2.89 Million	30,310 Added 6.37%	506,168 $38.8 Million
Q2 2019 Aug 05, 2019	BUY	$54.2 - $85.95 $25.8 Million - $40.9 Million	475,858 New	475,858 $40.9 Million

Others Institutions Holding RGEN

# of Institutions

476

Shares Held

54.5M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Repligen Corp Transaction History